Cardio Diagnostics Holdings, Inc. (CDIO)
2.02
-0.01
(-0.49%)
USD |
NASDAQ |
Sep 18, 16:00
2.02
0.00 (0.00%)
After-Hours: 20:00
Cardio Diagnostics Holdings Enterprise Value : 0.7612M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 0.7612M |
| September 17, 2026 | 0.7908M |
| September 16, 2026 | 0.702M |
| September 15, 2026 | 0.702M |
| September 14, 2026 | 0.9092M |
| September 11, 2026 | 0.7908M |
| September 10, 2026 | 0.6428M |
| September 09, 2026 | 0.9092M |
| September 08, 2026 | 0.5836M |
| September 04, 2026 | 0.2877M |
| September 03, 2026 | 0.1989M |
| September 02, 2026 | 0.2285M |
| September 01, 2026 | 0.2581M |
| August 31, 2026 | 0.3173M |
| August 28, 2026 | 0.2581M |
| August 27, 2026 | 0.3173M |
| August 26, 2026 | 0.4948M |
| August 25, 2026 | 0.4356M |
| August 24, 2026 | 0.48M |
| August 21, 2026 | 0.7908M |
| August 20, 2026 | 1.324M |
| August 19, 2026 | 0.6724M |
| August 18, 2026 | 0.4356M |
| August 17, 2026 | 0.6724M |
| August 14, 2026 | 0.8204M |
| Date | Value |
|---|---|
| August 13, 2026 | 0.7316M |
| August 12, 2026 | 1.176M |
| August 11, 2026 | 0.1989M |
| August 10, 2026 | -0.1563M |
| August 07, 2026 | 0.0805M |
| August 06, 2026 | -0.3042M |
| August 05, 2026 | -0.0379M |
| August 04, 2026 | -0.0675M |
| August 03, 2026 | -0.3634M |
| July 31, 2026 | -0.6002M |
| July 30, 2026 | -0.5706M |
| July 29, 2026 | -0.541M |
| July 28, 2026 | -0.6002M |
| July 27, 2026 | -0.4226M |
| July 24, 2026 | -0.6298M |
| July 23, 2026 | -0.3933M |
| July 22, 2026 | -0.245M |
| July 21, 2026 | -0.2746M |
| July 20, 2026 | -0.393M |
| July 17, 2026 | -0.1267M |
| July 16, 2026 | -0.2154M |
| July 15, 2026 | 0.0805M |
| July 14, 2026 | 0.1101M |
| July 13, 2026 | 0.0805M |
| July 10, 2026 | 0.1989M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -57.27M |
| Exicure, Inc. | 6.123M |
| Century Therapeutics, Inc. | 254.77M |
| Absci Corp. | 1.458B |
| Celularity, Inc. | 106.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.502M |
| Revenue (Quarterly) | 0.0054M |
| Total Expenses (Quarterly) | 1.507M |
| EPS Diluted (Quarterly) | -0.5073 |
| Gross Profit Margin (Quarterly) | -824.1% |
| Profit Margin (Quarterly) | -27.81K% |
| Earnings Yield | -144.3% |
| Normalized Earnings Yield | -144.29 |